Proteolysis Targeting Chimera (PROTAC) for Macrophage Migration Inhibitory Factor (MIF) Has Anti‐Proliferative Activity in Lung Cancer Cells
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Proteolysis Targeting Chimera (PROTAC) for Macrophage Migration Inhibitory Factor (MIF) Has Anti‐Proliferative Activity in Lung Cancer Cells ; day:26 ; month:06 ; year:2021 ; extent:10
Angewandte Chemie / International edition. International edition ; (26.06.2021) (gesamt 10)
- Urheber
-
Xiao, Zhangping
Song, Shanshan
Chen, Deng
van Merkerk, Ronald
van der Wouden, Petra E.
Cool, Robbert H.
Quax, Wim J.
Poelarends, Gerrit
Melgert, Barbro N.
Dekker, Frank J.
- DOI
-
10.1002/anie.202101864
- URN
-
urn:nbn:de:101:1-2021062615253561239167
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:01 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Xiao, Zhangping
- Song, Shanshan
- Chen, Deng
- van Merkerk, Ronald
- van der Wouden, Petra E.
- Cool, Robbert H.
- Quax, Wim J.
- Poelarends, Gerrit
- Melgert, Barbro N.
- Dekker, Frank J.
Ähnliche Objekte (12)
Proteolysis Targeting Chimera (PROTAC) for Macrophage Migration Inhibitory Factor (MIF) Has Anti‐Proliferative Activity in Lung Cancer Cells
Anti-proliferative activity of silver nanoparticles
Proteolysis-targeting chimera (PROTAC) for targeted protein degradation and cancer therapy
Proteolysis targeting chimera (PROTAC)-driven antibody internalization of oncogenic cell surface receptors
Repression of anti-proliferative factor Tob1in osteoarthritic cartilage
Development of the first selective proteolysis targeting chimera for the FK506-binding protein 51
Chimera
Chimera
Anti-proliferative activity of Artemisia marschalliana on cancerous cell lines
Der anti-proliferative Effekt von Metformin bei humanen kolorektalen Karzinomzelllinien
Anti-proliferative therapy for HIV cure: a compound interest approach
Degradation of neurodegenerative disease-associated TDP-43 aggregates and oligomers via a proteolysis-targeting chimera
Proteolysis Targeting Chimera (PROTAC) for Macrophage Migration Inhibitory Factor (MIF) Has Anti‐Proliferative Activity in Lung Cancer Cells
Anti-proliferative activity of silver nanoparticles
Proteolysis-targeting chimera (PROTAC) for targeted protein degradation and cancer therapy
Proteolysis targeting chimera (PROTAC)-driven antibody internalization of oncogenic cell surface receptors
Repression of anti-proliferative factor Tob1in osteoarthritic cartilage
Development of the first selective proteolysis targeting chimera for the FK506-binding protein 51
Chimera
Chimera
Anti-proliferative activity of Artemisia marschalliana on cancerous cell lines
Der anti-proliferative Effekt von Metformin bei humanen kolorektalen Karzinomzelllinien
Anti-proliferative therapy for HIV cure: a compound interest approach
Degradation of neurodegenerative disease-associated TDP-43 aggregates and oligomers via a proteolysis-targeting chimera
Proteolysis Targeting Chimera (PROTAC) for Macrophage Migration Inhibitory Factor (MIF) Has Anti‐Proliferative Activity in Lung Cancer Cells
Anti-proliferative activity of silver nanoparticles
Proteolysis-targeting chimera (PROTAC) for targeted protein degradation and cancer therapy
Proteolysis targeting chimera (PROTAC)-driven antibody internalization of oncogenic cell surface receptors
Repression of anti-proliferative factor Tob1in osteoarthritic cartilage
Development of the first selective proteolysis targeting chimera for the FK506-binding protein 51
Chimera
Chimera
Anti-proliferative activity of Artemisia marschalliana on cancerous cell lines
Der anti-proliferative Effekt von Metformin bei humanen kolorektalen Karzinomzelllinien
Anti-proliferative therapy for HIV cure: a compound interest approach